Fact CheckerSign in

NCT06575439Recruiting

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK

Source: ClinicalTrials.gov · Last updated 12 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom. The main questions it aims to answer are: * To describe characteristics such as demographics, co-morbidities and environmental exposures * To describe participant pathways including presentation mode and symptoms to understand if earlier diagnosis would be possible * To describe participant outcomes such as cancer stage, treatment and mortality * To quantitatively or qualitatively measure modifiable and non-modifiable factors that may be associated with LCINS including environmental measures, blood tests and genomic data. Participants will currently have no change to their usual care.

Status (registry)
Recruiting
Study type
Observational
Enrollment
225 (estimated)
First submitted
21 Aug 2024
Start date
17 Sept 2024
Primary completion date
Sept 2029
Lead sponsor
University College London Hospitals
Diseases
Lung cancer
NCT number
NCT06575439

What you commit to

  • Study type: Observational
  • Planned participants: 225
  • From 17 Sept 2024 to the primary completion date, Sept 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants who have ever smoked cigarettes or tobacco will be excluded; this is defined as:
    • More than 100 cigarettes or 75g tobacco in their lifetime
    • Those who have received a prescription for nicotine replacement therapy

Other

  • For prospective participants, those who cannot consent will be excluded

Who the study is looking for

  • All adult participants from age of 18 who are diagnosed or treated with primary lung cancer through radiology or histology at any participating study site

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University College London Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.